Literature DB >> 27054877

Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system.

Seunggu J Han1, Krystof Bankiewicz1, Nicholas A Butowski1, Paul S Larson1, Manish K Aghi1.   

Abstract

Local delivery of therapeutic agents into the brain has many advantages; however, the inability to predict, visualize and confirm the infusion into the intended target has been a major hurdle in its clinical development. Here, we describe the current workflow and application of the interventional MRI (iMRI) system for catheter placement and real time visualization of infusion. We have applied real time convection-enhanced delivery (CED) of therapeutic agents with iMRI across a number of different clinical trials settings in neuro-oncology and movement disorders. Ongoing developments and accumulating experience with the technique and technology of drug formulations, CED platforms, and iMRI systems will continue to make local therapeutic delivery into the brain more accurate, efficient, effective and safer.

Entities:  

Keywords:  Interventional MRI; catheter placement; convection enhanced delivery; drug delivery; real time

Mesh:

Year:  2016        PMID: 27054877      PMCID: PMC5553275          DOI: 10.1080/14737175.2016.1175939

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  14 in total

1.  Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen.

Authors:  Michal T Krauze; Ryuta Saito; Charles Noble; John Bringas; John Forsayeth; Tracy R McKnight; John Park; Krystof S Bankiewicz
Journal:  Exp Neurol       Date:  2005-08-16       Impact factor: 5.330

2.  Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain.

Authors:  R Mark Richardson; Adrian P Kells; Alastair J Martin; Paul S Larson; Philip A Starr; Peter G Piferi; Geoffrey Bates; Lisa Tansey; Kathryn H Rosenbluth; John R Bringas; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Stereotact Funct Neurosurg       Date:  2011-04-14       Impact factor: 1.875

3.  Optimized cannula design and placement for convection-enhanced delivery in rat striatum.

Authors:  Dali Yin; John Forsayeth; Krystof S Bankiewicz
Journal:  J Neurosci Methods       Date:  2009-12-22       Impact factor: 2.390

4.  Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.

Authors:  C Warren Olanow; Raymond T Bartus; Tiffany L Baumann; Stewart Factor; Nicholas Boulis; Mark Stacy; Dennis A Turner; William Marks; Paul Larson; Phillip A Starr; Joseph Jankovic; Richard Simpson; Ray Watts; Barton Guthrie; Kathleen Poston; Jaimie M Henderson; Matthew Stern; Gordon Baltuch; Christopher G Goetz; Christopher Herzog; Jeffrey H Kordower; Ron Alterman; Andres M Lozano; Anthony E Lang
Journal:  Ann Neurol       Date:  2015-06-10       Impact factor: 10.422

5.  Poor drug distribution as a possible explanation for the results of the PRECISE trial.

Authors:  John H Sampson; Gary Archer; Christoph Pedain; Eva Wembacher-Schröder; Manfred Westphal; Sandeep Kunwar; Michael A Vogelbaum; April Coan; James E Herndon; Raghu Raghavan; Martin L Brady; David A Reardon; Allan H Friedman; Henry S Friedman; M Inmaculada Rodríguez-Ponce; Susan M Chang; Stephan Mittermeyer; David Croteau; Raj K Puri
Journal:  J Neurosurg       Date:  2010-08       Impact factor: 5.115

6.  An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: preliminary evaluation of targeting accuracy.

Authors:  Paul S Larson; Philip A Starr; Geoffrey Bates; Lisa Tansey; R Mark Richardson; Alastair J Martin
Journal:  Neurosurgery       Date:  2012-03       Impact factor: 4.654

7.  Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

Authors:  Sandeep Kunwar; Michael D Prados; Susan M Chang; Mitchel S Berger; Frederick F Lang; Joseph M Piepmeier; John H Sampson; Zvi Ram; Philip H Gutin; Robert D Gibbons; Kenneth D Aldape; David J Croteau; Jeffrey W Sherman; Raj K Puri
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

8.  A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease.

Authors:  Shin-ichi Muramatsu; Ken-ichi Fujimoto; Seiya Kato; Hiroaki Mizukami; Sayaka Asari; Kunihiko Ikeguchi; Tadataka Kawakami; Masashi Urabe; Akihiro Kume; Toshihiko Sato; Eiju Watanabe; Keiya Ozawa; Imaharu Nakano
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

9.  Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Authors:  C W Christine; P A Starr; P S Larson; J L Eberling; W J Jagust; R A Hawkins; H F VanBrocklin; J F Wright; K S Bankiewicz; M J Aminoff
Journal:  Neurology       Date:  2009-10-14       Impact factor: 9.910

10.  Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.

Authors:  Sabine Mueller; Mei-Yin Polley; Benjamin Lee; Sandeep Kunwar; Christoph Pedain; Eva Wembacher-Schröder; Stephan Mittermeyer; Manfred Westphal; John H Sampson; Michael A Vogelbaum; David Croteau; Susan M Chang
Journal:  J Neurooncol       Date:  2010-06-20       Impact factor: 4.130

View more
  7 in total

1.  Venous Thromboembolism during Interventional MRI-Guided Stereotactic Surgery.

Authors:  Adam J Kundishora; Dario J Englot; Philip A Starr; Alastair J Martin; Paul S Larson
Journal:  Stereotact Funct Neurosurg       Date:  2018-03-01       Impact factor: 1.875

2.  New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.

Authors:  Nundia Louis; Sharon Liu; Xingyao He; Daryl C Drummond; Charles O Noble; Stewart Goldman; Sabine Mueller; Krystof Bankiewicz; Nalin Gupta; Rintaro Hashizume
Journal:  J Neurooncol       Date:  2017-11-23       Impact factor: 4.130

Review 3.  Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?

Authors:  Richard J Price; Delaney G Fisher; Jung Soo Suk; Justin Hanes; Han Seok Ko; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2019-03-25       Impact factor: 10.338

Review 4.  Convection-Enhanced Delivery in Children: Techniques and Applications.

Authors:  K Aquilina; A Chakrapani; L Carr; M A Kurian; D Hargrave
Journal:  Adv Tech Stand Neurosurg       Date:  2022

5.  Nanomaterials for convection-enhanced delivery of agents to treat brain tumors.

Authors:  Young-Eun Seo; Tom Bu; W Mark Saltzman
Journal:  Curr Opin Biomed Eng       Date:  2017-09-22

Review 6.  Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.

Authors:  Umberto Tosi; Christopher S Marnell; Raymond Chang; William C Cho; Richard Ting; Uday B Maachani; Mark M Souweidane
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

7.  Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.

Authors:  John H Rossmeisl; Denise Herpai; Mindy Quigley; Thomas E Cecere; John L Robertson; Ralph B D'Agostino; Jonathan Hinckley; Stephen B Tatter; Peter J Dickinson; Waldemar Debinski
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.